| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4611a37bd8ad6403dc3612d45ac5c78a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b4621ae6b94ebb3ab082a62a3f62e60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79cbef3e127d95f39eae29e2b63940c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5c31e3212554945576bd5de3d8e32abc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-04 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-57563
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-2278 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-575
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 |
| filingDate |
2014-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4938a57e3fe9d877b084b694c15a88b4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9462e49da554929d535ca3cdd7092d96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0486d8e27e0c925a6fb6e2dda1c75e4d |
| publicationDate |
2016-02-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2016045572-A1 |
| titleOfInvention |
Peptides comprising non-natural amino acids and methods of making and using the same |
| abstract |
This invention relates to novel compositions comprising analogs of naturally occurring polypeptides, wherein the analog comprises an α-amino acid and at least one β-amino acid. Administration of the compositions may be used for effecting treatment or prevention of a plurality of disease states caused by dysfunctional biochemical or biological pathways. The compositions and methods of this invention are particularly useful to identify novel therapeutic modulators of in-vivo receptor activity with extended half-lives and relevant bioactivity as compared to the naturally translated polypeptides upon which the analogs are derived. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019240881-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11786580-B2 |
| priorityDate |
2013-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |